Should Moderna Before Aug.: A Clear Investor Guide for 2026
As Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
A quick guide to reputable sources for index level data, plus tips on choosing datasets and validating their reliability for analysis.
24,978 articlesAs Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Memory-chip stocks tumbled after a Korean market crash rippled into U.S. markets, led by SanDisk and Micron as risk-o...
A leading economist argues AI-driven productivity is slow to spread beyond software, suggesting investors should brac...
Momentum can carry stocks far, but savvy investors still want a plan. This article profiles three soaring stocks that...
Nvidia’s 2026 story isn’t all hype. This guide explains why the stock is under pressure, the role of the Magnificent ...
Nvidia has built a fortress around AI-driven growth, but one number could alter the trajectory. This article breaks d...
A wave of exits from startup builders of large language models is shrinking the field while giants pull further ahead...
The Nasdaq surged in the first half of 2026 as AI infrastructure names led a broad rally. Three AI stocks are showing...
A prominent market strategist argues the brutal tech and crypto rout may be nearing a bottom as risk assets stabilize...
A top Nomura strategist says equities are priced for chaos, but the odds of a sweeping market crash remain low as dat...
Early indicators point to a modest 2027 social security cola, around 2.8%, but higher Medicare premiums could erode t...
The latest inflation data shows stronger yearly gains but softer monthly momentum, putting Bitcoin in a delicate posi...